Opus Genetics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.2 | $11.0 | $19.0 | $39.9 | $0.6 |
| Operating income | -$38.6 | -$62.1 | -$10.6 | $18.2 | -$22.7 |
| Net income | -$49.6 | -$57.5 | -$10.0 | $17.9 | -$56.7 |
Shares outstanding 83.2M · Free float 58.5%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.